A Multidimensional CT-Based Tumor Location Metric for Predicting Lymph Node Metastasis and Occult Lymph Node Metastasis in Lung Adenocarcinoma
Technology in Cancer Research & Treatment · 2026
DOI: 10.1177/15330338261494765 ↗Kurz gefasst
Fachartikel in der Zeitschrift Technology in Cancer Research & Treatment, 2026. Verfasst von Licheng Wu und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Surgery, Daping Hospital, Army Medical University, Chongqing, P.R. China. Hauptthemen laut MEDLINE: Lymphatic Metastasis, Tomography, X-Ray Computed, Adenocarcinoma of Lung, Lung Neoplasms. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Development and Application of Artificial Intelligence-Assisted Precision Diagnosis and Treatment Decision-Making System for Lung Cancer Surgery.
Abstract (Originalsprache)
Introduction
Lymph node (LN) metastasis of lung adenocarcinoma, particularly occult lymph node metastasis (OLNM), remains difficult to predict using conventional imaging and basic positional parameters, adversely affecting prognosis. This study aimed to: (1) evaluate a new CT index (a/A + b/B) for predicting OLNM in cN0 patients, and (2) create and validate a nomogram for predicting LN metastasis probability in CT-suspected cases.
Methods
This single-center retrospective study involved 387 lung adenocarcinoma patients (225 non-LN, 84 OLNM, and 78 with CT-suspected/pathologically confirmed LN metastasis) who had surgery from 2016 to 2024. A spatial index (a/A + b/B) was developed to combine two perpendicular anatomical axes, vertical proximity to the interlobar fissure and horizontal proximity to the mediastinum/hilum, into one standardized metric.
Results
The combined ratio a/A + b/B was significantly lower in the OLNM and metastatic groups. A lower a/A + b/B was significantly associated with OLNM (OR = 0.175, 95% CI: 0.048–0.638, P = 0.007), suggesting a 0.1-unit decrease in the a/A + b/B ratio increased OLNM risk by 19%. A nomogram utilizing a/A + b/B differentiates CT-suspected LN metastasis from node-negative cases, showing AUCs of 0.83 (95% CI: 0.76–0.90) in training, 0.85(95% CI: 0.76–0.94) in internal validation, and 0.70(95% CI: 0.50–0.91) in external validation.
Conclusion
A ratio of a/A + b/B < 0.6 indicates a high OLNM risk in cN0 patients. This index can predict OLNM when LNs are small on CT, and a nomogram can differentiate CT-suspected LN metastasis from node-negative cases, meriting further study.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Thoracic Surgery, Daping Hospital, Army Medical University, Chongqing, P.R. China.
- Department of Pathology, Daping Hospital, Army Medical University, Chongqing, P.R. China.
- Department of Information, Daping Hospital, Army Medical University, Chongqing, P.R. China.
- College of Computer Science, Chongqing University, Chongqing, P.R. China.
ORCID-Profile: Bo Deng
Förderung
- Development and Application of Artificial Intelligence-Assisted Precision Diagnosis and Treatment Decision-Making System for Lung Cancer Surgery
Zitieren
APA
Wu, L., Shang, H., Mao, C., Wei, Z., Dai, F., Mei, L., Feng, Y., Hao, Z., Zhang, J., Wu, D., Wang, Y., & Deng, B. (2026). A Multidimensional CT-Based Tumor Location Metric for Predicting Lymph Node Metastasis and Occult Lymph Node Metastasis in Lung Adenocarcinoma. Technology in Cancer Research & Treatment. https://doi.org/10.1177/15330338261494765
Vancouver
Wu L, Shang H, Mao C, Wei Z, Dai F, Mei L, et al. A Multidimensional CT-Based Tumor Location Metric for Predicting Lymph Node Metastasis and Occult Lymph Node Metastasis in Lung Adenocarcinoma. Technology in Cancer Research & Treatment. 2026. doi:10.1177/15330338261494765
BibTeX
@article{Wu2026,
author = {Wu, Licheng and Shang, Haoran and Mao, Chengyi and Wei, Zhi and Dai, Fuqiang and Mei, Longyong and Feng, Yonggeng and Hao, Zhipeng and Zhang, Jingge and Wu, Dongdong and Wang, Yi and Deng, Bo},
title = {A Multidimensional CT-Based Tumor Location Metric for Predicting Lymph Node Metastasis and Occult Lymph Node Metastasis in Lung Adenocarcinoma},
journal = {Technology in Cancer Research & Treatment},
year = {2026},
doi = {10.1177/15330338261494765}
}
EUVIMED